The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAccrol Gp Regulatory News (ACRL)

Share Price Information for Accrol Gp (ACRL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 38.60
Bid: 38.60
Ask: 38.70
Change: 0.00 (0.00%)
Spread: 0.10 (0.259%)
Open: 38.60
High: 0.00
Low: 0.00
Prev. Close: 38.60
ACRL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

8 Feb 2024 07:00

RNS Number : 4074C
Accrol Group Holdings PLC
08 February 2024
 

8 February 2024

 

Accrol Group Holdings plc

("Accrol", the "Group" or the "Company")

 

Awards under Long Term Incentive Plan and PDMR dealing

 

Accrol (AIM: ACRL), the UK's leading independent tissue converter, announces the second grant of options to executive Directors and certain senior management under the Long-Term Incentive Plan ("LTIP") announced on 5 March 2021.

 

The LTIP was established to incentivise management to deliver long-term value creation for shareholders and ensure alignment with shareholder interests.

 

Background

 

The LTIP is based on market standard annual awards and is limited to a maximum of 5% of the issued share capital of the Company over its five-year life assuming all existing LTIP options are exercised.

 

All awards made under the LTIP will be made by the granting of nil-cost options established in accordance with the rules of the LTIP and vesting is subject to adjusted EBITDA targets in line with the LTIP rules.

 

The Remuneration Committee has discretion to amend these terms to take account of, for example, corporate activities such as acquisitions to ensure that the performance targets remain appropriate. Malus and clawback provisions are also in place to reduce or recover any awards for criteria such as any material misstatement of the financial statements, a serious breach of the Company's code of ethics or a serious health and safety issue.

 

Award size, performance conditions and dilution

 

On 5 February 2024, options over 2,594,718 shares in aggregate (the "2024 Awards") were granted under the LTIP, including those set out below which were granted to directors and other persons discharging managerial responsibility:

 

Director / PDMR

Role

Number of shares over which 2024 Awards made

Dan Wright

Executive Chairman

488,709

Gareth Jenkins

Chief Executive Officer

1,055,065

Chris Welsh

Chief Financial Officer

401,700

Graham Cox

PDMR

506,417

 

The 2024 Awards are subject to the below Adjusted EBITDA targets measured over the performance period ending on 30 April 2026 and are summarised below:

 

Adjusted EBITDA for FY2026

Percentage of the 2024 Award that may vest

Less than £21.0m

0%

Between £21.0m and £23.0m

Between 25% and 100%

£23.0m or greater

100%

 

If the maximum targets are met in FY26, the total dilutive impact of the 2024 Awards will be 0.8%. The maximum aggregate dilutive effect of awards then issued under the LTIP will stand at 4.94% of the fully diluted share capital of the Company assuming all existing LTIP options are exercised. 

 

 

For further information, please contact:

 

Accrol Group Holdings plc

Dan Wright, Executive Chairman

Via Belvedere Communications

Gareth Jenkins, Chief Executive Officer

Christopher Welsh, Chief Financial Officer

Zeus (Nominated Adviser & Broker) 

Dan Bate / Jordan Warburton

Tel: +44 (0) 161 831 1512

Dominic King

Tel: +44 (0) 203 829 5000

Shore Capital Stockbrokers (Joint Broker)

Tel: +44 (0) 20 7408 4090

Malachy McEntyre/ Mark Percy / James Thomas / Isobel Jones

 

Belvedere Communications Limited

Cat Valentine

Tel: +44 (0) 7715 769 078

Keeley Clarke

Tel: +44 (0) 7967 816 525

accrolpr@belvederepr.com

 

Overview of Accrol

 

Accrol Group Holdings plc is a leading tissue converter and supplier of toilet tissues, kitchen rolls, facial tissues, and wet wipes to many of the UK's leading discounters and grocery retailers across the UK. The Group now operates from five manufacturing sites suppling the UK tissue wet wipes market valued at c£3.0bn at retail sales value.

 

For more information, please visit www.accrol.co.uk.

 

Link for Accrol Today video: https://www.accrol.co.uk/our-business/

 

The below information and notification is made in accordance with the EU Market Abuse Regulation.

 

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Dan Wright

2

Reason for the notification

a)

Position/status

Executive Chairman

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Accrol Group Holdings plc

b)

LEI

213800MC56M5G69RJ226

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of £0.001 each

 

 

 

ISIN: GB00BZ6VT592

b)

Nature of the transaction

Grant of options over ordinary shares under the Company's new LTIP

c)

Price(s) and volume(s)

a) Volume: 488,709Price : £0.001

d)

Aggregated information

- Aggregated volume

- Price

 

a) Volume: 488,709

Price : £0.001

e)

Date of the transaction

a) 5 February 2024

f)

Place of the transaction

a) Off market transaction

 

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Gareth Jenkins

2

Reason for the notification

a)

Position/status

Chief Executive Officer

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Accrol Group Holdings plc

b)

LEI

213800MC56M5G69RJ226

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of £0.001 each

 

 

 

ISIN: GB00BZ6VT592

b)

Nature of the transaction

Grant of options over ordinary shares under the Company's new LTIP

c)

Price(s) and volume(s)

a) Volume: 1,055,065Price : £0.001

d)

Aggregated information

- Aggregated volume

- Price

 

a) Volume: 1,055,065

Price : £0.001

e)

Date of the transaction

a) 5 February 2024

f)

Place of the transaction

a) Off market transaction

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Chris Welsh

2

Reason for the notification

a)

Position/status

Chief Financial Officer

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Accrol Group Holdings plc

b)

LEI

213800MC56M5G69RJ226

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of £0.001 each

 

 

 

ISIN: GB00BZ6VT592

b)

Nature of the transaction

Grant of options over ordinary shares under the Company's new LTIP

c)

Price(s) and volume(s)

a) Volume: 401,700Price : £0.001

d)

Aggregated information

- Aggregated volume

- Price

 

a) Volume: 401,700

Price : £0.001

e)

Date of the transaction

a) 5 February 2024

f)

Place of the transaction

a) Off market transaction

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Graham Cox

2

Reason for the notification

a)

Position/status

Chief Operating Officer

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Accrol Group Holdings plc

b)

LEI

213800MC56M5G69RJ226

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of £0.001 each

 

 

 

ISIN: GB00BZ6VT592

b)

Nature of the transaction

Grant of options over ordinary shares under the Company's new LTIP

c)

Price(s) and volume(s)

a) Volume: 506,417Price : £0.001

d)

Aggregated information

- Aggregated volume

- Price

 

a) Volume: 506,417

Price : £0.001

e)

Date of the transaction

a) 5 February 2024

f)

Place of the transaction

a) Off market transaction

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFFFIIFIIDIIS
Date   Source Headline
8th Jan 20197:00 amRNSTrading Update
23rd Nov 20187:00 amRNSAccrol Group to present at Mello London
30th Oct 201811:37 amRNSResult of AGM
30th Oct 20187:00 amRNSPDMR Dealings
29th Oct 201811:24 amRNSBoard and Board Committee Changes
10th Oct 20187:00 amRNSAppointment of Non Executive Director
28th Sep 20187:00 amRNSAudited Final Results and Notice of AGM
26th Sep 20187:00 amRNSUnaudited Final Results 2018 and Banking Update
28th Aug 20187:00 amRNSBoard and Senior Management Changes
11th Jul 20187:00 amRNSNotice of Final Results
11th Jul 20187:00 amRNSDirectorate Change
9th Jul 20184:04 pmRNSHolding(s) in Company
18th Jun 20184:39 pmRNSDirector's Dealings
18th Jun 20187:00 amRNSHolding(s) in Company
12th Jun 20183:47 pmRNSDirectors' Dealings
12th Jun 20187:00 amRNSAccrol Leads the Way with Plastic-free Packaging
11th Jun 20187:00 amRNSAppointment of Chief Financial Officer
7th Jun 20187:00 amRNSResult of Open Offer
4th Jun 20182:20 pmRNSHolding(s) in Company
4th Jun 20187:00 amRNSHolding(s) in Company
1st Jun 20188:01 amRNSDirectors' Dealings
1st Jun 20188:00 amRNSPlacing Shares Admitted and Total Voting Rights
31st May 201811:35 amRNSResult of General Meeting
22nd May 20186:25 pmRNSPosting of Cricular
22nd May 20187:00 amRNSOpen Offer
22nd May 20187:00 amRNSTR1
15th May 20185:16 pmRNSPosting of Circular
15th May 20183:08 pmRNSProposed Placing to raise £8 million
3rd May 20187:00 amRNSHolding(s) in Company
1st May 20182:06 pmRNSSecond Price Monitoring Extn
1st May 20182:00 pmRNSPrice Monitoring Extension
1st May 20187:00 amRNSRevised Banking Arrangements & Operational Update
4th Apr 20185:06 pmRNSDirector Shareholding
29th Mar 20183:26 pmRNSTR1: Standard form
29th Mar 20187:00 amRNSTR-1: Standard form
27th Mar 20183:43 pmRNSStatement re Share Price Movement
26th Mar 20184:41 pmRNSSecond Price Monitoring Extn
26th Mar 20184:35 pmRNSPrice Monitoring Extension
21st Mar 201812:32 pmRNSHolding(s) in Company
19th Mar 20187:00 amRNSTrading Update
15th Feb 20185:55 pmRNSDirector/PDMR Shareholding
13th Feb 20187:00 amRNSDirector/PDMR Shareholding
8th Feb 20184:31 pmRNSDirector/PDMR Shareholding
5th Feb 20187:00 amRNSBoard Changes
23rd Jan 20181:16 pmRNSPDMR Dealings
22nd Jan 20187:01 amRNSInterim Results for six months ended 31 Oct 2017
22nd Jan 20187:00 amRNSBoard Change
17th Jan 20183:25 pmRNSUpdate on Health and Safety Incident
4th Jan 20187:00 amRNSTR-1: Standard form
3rd Jan 20187:00 amRNSNotice of Half Year Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.